Work

114 Real-world evidence from the German cystic fibrosis registry on off- label treatment effects of elexacaftor/tezacaftor/ivacaftor

Year: 2025

Type: article

Source: Journal of Cystic Fibrosis

DOI: 10.1016/s1569-1993(25)01733-3

Authors: M. Stahl, F. Gerts, S. Hafkemeyer, J. Wosniok, L. Naehrlich

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414716573

FWCI:

Cites:

Cited by:

Related to: 10